Dermoscopy of inflammatory breast cancer

Vallone, María Gabriela; González, Virginia; Casas, José Guadalupe; Larralde, Margarita

doi:10.1590/abd1806-4841.20186806

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…14 Histological diagnosis of IBC is represented in (Figure 2). 15 There are no recognized risk factors for IBC at present time. Although, the investigated characteristics of IBC are clarified by numerous epidemiological research studies which include black race, high body mass index, age, and region as the most significant suspected risk factors linked to this disease.…”

Section: Clinical Picture Manifestations and Diagnosismentioning

confidence: 99%

An overview of inflammatory breast cancer

Siddiqui

Alsarhan

Almutairi

et al. 2022

Int J Community Med Public Health

View full text Add to dashboard Cite

Inflammatory breast cancer is an uncommon and severe malignancy that frequently goes undiagnosed at first because it presents similarly to more benign breast diseases like mastitis, resulting in delayed treatment. Inflammatory breast cancer affects 1% to 5% of all occurrences of breast cancer and accounts for 8% to 10% of all breast cancer-related deaths. Erythema, skin abnormalities, nipple inversion, edema, and warmth of the affected breast are all signs of inflammatory breast cancer. Recognized risk factors for inflammatory breast cancer include young age at the time of diagnosis, obesity and African American ethnicity. Rapid onset within 3 months and pathologic evidence of invasive carcinoma leads to diagnosis of disease further including erythema occupying at least one-third of the breast, tumour may or may not be present in this case. Chemotherapy, surgery, and radiation make up the trimodal therapy used to treat inflammatory breast cancer. A modified radical mastectomy performed as part of an aggressive surgical strategy improves survival rates. Although patients with inflammatory breast cancer have worse outcomes than those with noninflammatory breast cancer, those who complete trimodal therapy have a positive locoregional control rate, highlighting the significance of an early diagnosis. Physicians must be aware and examine any clinical manifestation of inflammatory breast cancer if present to make a prompt diagnosis and refer patient for expert care timely also awareness and cancer screening can help in prevention of disease. The purpose of this research is to review the available information about an overview of inflammatory breast cancer.

show abstract

Section: Clinical Picture Manifestations and Diagnosismentioning

confidence: 99%

An overview of inflammatory breast cancer

Siddiqui

Alsarhan

Almutairi

et al. 2022

Int J Community Med Public Health

View full text Add to dashboard Cite

show abstract

“…4 Inflammatory breast carcinoma memiliki gambaran makroskopis berupa eritema difus dan edema pada ≥1/3 luas kulit payudara (Gambar 2). 16 Gambaran mikroskopis khas pada inflammatory breast carcinoma adalah ditemukannya karsinoma dengan banyak emboli limfatik di dermis. 4 Pada penelitian ini ditemukan 1 kasus dengan diagnosis klinis mastitis dan gambaran radiologis berupa penebalan kulit abnormal yang luas di area payudara.…”

unclassified

Histomorphological and Demographic Profile of Breast Carcinoma in Anatomical Pathology Department FKUI/RSCM 2016-2019

Wongkar¹,

Hellyanti²,

Hayati³

2022

MPI

View full text Add to dashboard Cite

BackgroundInvasive breast carcinoma (IBC) is the most commonly diagnosed cancer in woman in the world and Indonesia. IBC is classified into two main categories: IBC of no special type (NST) and special types. This retrospective study aims to provide histomorphological profile of mastectomy cases of IBC in Anatomical Pathology Department, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital (PA FKUI/RSCM) 2016-2019.MethodsThis is a descriptive research with cross-sectional design of mastectomy cases, using secondary data from the archives of PA FKUI/RSCM, starting from 2016- 2019. Collecting clinical data as well as observing several histopathologic parameters including histological type, grade, atypical mitotic features, lymphovascular invasion, and lymph node metastases. Tumour classification was made based on the WHO breast criteria in 2019.ResultsDuring the 2016-2019 period there were 144 cases of IBC. 99.3% of cases occurred in female patients, mostly in the age group from 40 to 59 years and unilateral. The majority had tumour sizes ranging >2-5 cm and were stage II. About a third of cases had received neoadjuvant chemotherapy, most commonly in advanced local stage tumors. Most histologic type (65.3%) were IBC of NST and 52.8% of cases were grade 2. There were 92 (63.4%) cases with atypical mitotic features, most commonly found in stage III. Lymphovascular invasion was found in 38.9% of cases and lymph node metastasis was found in 63.2% of cases.ConclusionIBC is the most common cancer in woman, with the most common histologic type were IBC, grade 2, stage II or more. Most of the cases show atypical mitosis, which is most commonly found in stage III. The findings of lymphovascular invasion did not always coincide with the findings of lymph node metastases.

show abstract

Dermoscopy of inflammatory breast cancer

Cited by 2 publications

References 5 publications

An overview of inflammatory breast cancer

An overview of inflammatory breast cancer

Histomorphological and Demographic Profile of Breast Carcinoma in Anatomical Pathology Department FKUI/RSCM 2016-2019

Contact Info

Product

Resources

About